Simplex Trading’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-47,300
Closed -$96K 9840
2025
Q2
$96K Buy
47,300
+36,800
+350% +$59.9K ﹤0.01% 5281
2025
Q1
$13K Sell
10,500
-400
-4% -$851 ﹤0.01% 6927
2024
Q4
$28K Sell
10,900
-71,100
-87% -$226K ﹤0.01% 6428
2024
Q3
$149K Buy
82,000
+81,100
+9,011% +$152K ﹤0.01% 4827
2024
Q2
$1K Sell
900
-4,400
-83% -$8.54K ﹤0.01% 8533
2024
Q1
$12K Buy
+5,300
New +$11.3K ﹤0.01% 7489
2023
Q4
Sell
-1,000
Closed -$1K 9601
2023
Q3
$1K Sell
1,000
-6,200
-86% -$9.75K ﹤0.01% 8395
2023
Q2
$11K Sell
7,200
-11,400
-61% -$22.3K ﹤0.01% 7335
2023
Q1
$39K Buy
18,600
+6,500
+54% +$19.9K ﹤0.01% 6208
2022
Q4
$44K Sell
12,100
-6,400
-35% -$8.38K ﹤0.01% 6036
2022
Q3
$13K Sell
18,500
-12,100
-40% -$9.72K ﹤0.01% 8000
2022
Q2
$23K Sell
30,600
-117,100
-79% -$87.3K ﹤0.01% 7451
2022
Q1
$133K Buy
147,700
+121,200
+457% +$406K ﹤0.01% 5737
2021
Q4
$212K Buy
26,500
+5,200
+24% +$39.6K ﹤0.01% 5111
2021
Q3
$141K Hold
21,300
﹤0.01% 6129
2021
Q2
$143K Buy
21,300
+20,729
+3,630% +$134K ﹤0.01% 6208
2021
Q1
$377K Buy
+571
New +$2.92K ﹤0.01% 3796
2020
Q2
Sell
-2
Closed -$1K 8197
2020
Q1
$1K Buy
+2
New +$15 ﹤0.01% 7398
2019
Q1
Sell
-1
Closed -$1K 7702
2018
Q4
$1K Buy
+1
New +$18 ﹤0.01% 6773

Other funds holding PRQR

Simplex Trading's PRQR Position: Q1 2026 in Review

Simplex Trading reduced its ProQR Therapeutics (PRQR) stake by 44% in Q1 2026, selling an estimated $31.8K and leaving 24,868 shares worth $40.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6105.

Simplex Trading first reported a position in PRQR in Q1 2019 and has held it in 22 quarters since. The position peaked at $807K in Q1 2021. 69 funds tracked by Wall St. Rank hold PRQR as of Q1 2026.

  • Simplex Trading held 24,868 shares of ProQR Therapeutics worth $40.3K as of Q1 2026.
  • Simplex Trading sold 19,401 ProQR Therapeutics shares in Q1 2026, an estimated $31.8K.
  • ProQR Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6105 holding.
  • Simplex Trading first reported a position in ProQR Therapeutics in Q1 2019 and has held it in 22 quarters since.
  • Simplex Trading's ProQR Therapeutics position peaked at $807K in Q1 2021.
  • 69 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.